The global cerebrospinal fluid (CSF) management market is projected to reach USD 1.56 billion by 2022 from an estimated USD 1.26 billion in 2017, at a CAGR of 4.4%. Growth in the cerebrospinal fluid (CSF) management market can be attributed to the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures and the growing geriatric. The growing healthcare market in developing economies is also expected to provide growth opportunities for players in the market. On the other hand, the dearth of trained professionals and complications related to CSF shunts may challenge market growth to a certain extent during the forecast period.
Full Report: http://www.prnewswire.co.in/news-releases/cerebrospinal-fluid-csf-management-market-worth-156-billion-usd-by-2022-682677961.html
The cerebrospinal fluid (CSF) management market is segmented on the basis of product, end user, and region. On the basis of product, the market is segmented into shunts and external drainage devices. The shunts segment accounted for the largest share of the cerebrospinal fluid (CSF) management market in 2017 and are projected to grow at the highest CAGR during the forecast period. The high growth of the shunts segment can be attributed to the growing number of shunting procedures performed worldwide as well as the increasing number of revision shunt surgeries owing to shunt malfunction and infections. The shunts segment is further segmented based on the shunt type and type of valve. On the basis of shunt type, the shunts segment is divided into ventriculoperitoneal (VP), ventriculoatrial (VA), ventriculopleural (VPL), and lumboperitoneal (LP). On the basis of valve type, the shunts market is categorized into fixed and adjustable valves.
Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownload.asp?id=160672575
On the basis of end user, the global cerebrospinal fluid (CSF) management market is segmented into pediatric, adult, and geriatric. The pediatric segment is expected to account for the largest share of the global cerebrospinal fluid (CSF) management market during the forecast period. This could be attributed to high prevalence of congenital hydrocephalus.
Geographically, Asia Pacific is slated to register the higher CAGR during the forecast period. High prevalence of congenital hydrocephalus in China, growing geriatric population in Japan, and increasing medical tourism in India and several RoAPAC countries are key factors contributing to the market growth in this region.